Skip to search formSkip to main contentSkip to account menu

Allogeneic Cellular Vaccine 1650-G

Known as: 1650-G, 1650-G Vaccine, 1650G 
A pluripotent, allogeneic, tumor cell vaccine composed of irradiated tumor cells from the non-small cell lung cancer (NSCLC) cell line 1650 and the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
First Report of a Novel Deletion Due to εγδβ-Thalassemia in a Chinese Family
Abstract A fetus of Chinese descent presented with ultrasound features of anemia at 20 weeks’ gestation. Father had low a mean… 
2011
2011
Pilot Study of 1650-G: A Simplified Cellular Vaccine for Lung Cancer
Introduction: Cancer immunotherapy is a conceptually attractive since it is highly specific and can deal with disseminated… 
2005
2005
269 Nasal Continuous Positive Airway Pressure Facilitates Early Neonatal Back Transfer
Introduction: Neonatal networks and dedicated intensive care retrieval systems are evolving in the United Kingdom. Early back… 
Review
2000
Review
2000
Early versus late discontinuation of oxygen in preterm or low birth weight infants.
BACKGROUND This section is under preparation and will be included in the next issue. OBJECTIVES In preterm or low birth weight… 
1995
1995
Heparin Causes Platelet Dysfunction and Induces Fibrinolysis Before the Institution of Cardiopulmonary Bypass
Abstract : Platelet dysfunction and increased fibrinolysis are the most important etiologic factors in the hemostatic defect… 
Highly Cited
1970
Highly Cited
1970
Lymphocyte reactivity in vitro. II. Soluble reconstituting factor permitting response of purified lymphocyte.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)